SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001575
Filing Date
2023-08-07
Accepted
2023-08-07 16:00:33
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20230630x10q.htm   iXBRL 10-Q 1227312
2 EX-10.1 atxs-20230630xex10d1.htm EX-10.1 80914
3 EX-10.2 atxs-20230630xex10d2.htm EX-10.2 106176
4 EX-31.1 atxs-20230630xex31d1.htm EX-31.1 11465
5 EX-31.2 atxs-20230630xex31d2.htm EX-31.2 11320
6 EX-32.1 atxs-20230630xex32d1.htm EX-32.1 6739
7 GRAPHIC atxs-20230630xex10d1001.jpg GRAPHIC 5864
  Complete submission text file 0001410578-23-001575.txt   5518930

Data Files

Seq Description Document Type Size
8 EX-101.SCH atxs-20230630.xsd EX-101.SCH 33286
9 EX-101.CAL atxs-20230630_cal.xml EX-101.CAL 38279
10 EX-101.DEF atxs-20230630_def.xml EX-101.DEF 153465
11 EX-101.LAB atxs-20230630_lab.xml EX-101.LAB 348217
12 EX-101.PRE atxs-20230630_pre.xml EX-101.PRE 238227
53 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20230630x10q_htm.xml XML 929124
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 231147460
SIC: 2834 Pharmaceutical Preparations